Signaling through PI3Kγ: a common platform for leukocyte, platelet and cardiovascular stress sensing

 

 Buy Article Permissions and Reprints

Summary

The concerted activation of leukocytes and vessels shapes multiple physiological and pathological responses. A large number of these processes shares a common signal transduction platform involving the activation of plasma membrane bound G protein-coupled receptors (GPCRs). This event is usually amplified by the production of different intra-cellular second messenger molecules. Among these mediators, the phosphorylated lipid phosphatidylinositol (3,4,5)-trisphosphate (PIP3) produced by phosphoinositide 3-kinase γ (PI3Kγ) has recently emerged as a crucial signal in both vascular and white blood cells. The generation of mice lacking PI3Kγ showed that the GPCR/PI3Kγ/PIP3 signaling pathway controls diverse immune modulatory and vascular functions like respiratory burst, cell recruitment, mast cell reactivity, platelet aggregation, endothelial activation as well as smooth muscle contractility. The relative specificity of these events suggests that blocking PI3Kγ function might turn out beneficial for diseases like inflammation, allergy, thrombosis, and major cardiovascular disorders like hypertension, thus offering a wide range of therapeutic opportunities.

• References

• 1 Graef IA, Chen F, Crabtree GR. NFAT signaling in vertebrate development. Curr Opin Genet Dev 2001; 11: 505-12.
  CrossrefPubMedGoogle Scholar
• 2 Hill-Eubanks DC, Gomez MF, Stevenson AS, Nelson MT. NFAT regulation in smooth muscle. Trends Cardiovasc Med 2003; 13: 56-62.
  CrossrefPubMedGoogle Scholar
• 3 Vanhaesebroeck B, Leevers SJ, Ahmadi K. et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70: 535-602.
  CrossrefPubMedGoogle Scholar
• 4 Vlahos CJ, Matter WF, Hui KY. et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-8.
  PubMedGoogle Scholar
• 5 Arcaro A, Wymann MP. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 1993; 296: 297-301.
  CrossrefPubMedGoogle Scholar
• 6 Hawkins PT, Jackson TR, Stephens LR. Plateletderived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activatinga PtdIns(4,5)P2 3-OH kinase. Nature 1992; 358: 157-9.
  CrossrefPubMedGoogle Scholar
• 7 Katso R, Okkenhaug K, Ahmadi K. et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001; 17: 615-75.
  CrossrefPubMedGoogle Scholar
• 8 Stephens LR, Eguinoa A, Erdjument-Bromage H. et al. The G beta gamma sensitivity of a PI3K is dependent upona tightly associated adaptor, p101. Cell 1997; 89: 105-14.
  CrossrefPubMedGoogle Scholar
• 9 Krugmann S, Hawkins PT, Pryer N. et al. Characterizing the interactions between the two subunits of the p101/p110gamma phosphoinositide 3-kinase and their role in the activation of this enzyme by G beta gamma subunits. J Biol Chem 1999; 274: 17152-8.
  CrossrefPubMedGoogle Scholar
• 10 Stoyanov B, Volinia S, Hanck T. et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 1995; 269: 690-3.
  CrossrefPubMedGoogle Scholar
• 11 Stephens L, Anderson K, Stokoe D. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998; 279: 710-4.
  CrossrefPubMedGoogle Scholar
• 12 Voigt P, Brock C, Nurnberg B. et al. Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase gamma. J Biol Chem 2005; 280: 5121-7.
  CrossrefPubMedGoogle Scholar
• 13 Suire S, Coadwell J, Ferguson GJ. et al. p84,a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr Biol 2005; 15: 566-70.
  CrossrefPubMedGoogle Scholar
• 14 Hwang JI, Fraser ID, Choi S. et al. Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA. Proc Natl Acad Sci U S A 2004; 101: 488-93.
  CrossrefPubMedGoogle Scholar
• 15 Walker EH, Perisic O, Ried C. et al. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 1999; 402: 313-20.
  CrossrefPubMedGoogle Scholar
• 16 Pacold ME, Suire S, Perisic O. et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 2000; 103: 931-43.
  CrossrefPubMedGoogle Scholar
• 17 Lopez-Ilasaca M, Gutkind JS, Wetzker R. Phosphoinositide 3-kinase gamma is a mediator of Gbetagamma-dependent Jun kinase activation. J Biol Chem 1998; 273: 2505-8.
  CrossrefPubMedGoogle Scholar
• 18 Rubio I, Rodriguez-Viciana P. et al. Interaction of Ras with phosphoinositide 3-kinase gamma. Biochem J 1997; 326: 891-5.
  CrossrefPubMedGoogle Scholar
• 19 Bondeva T, Pirola L, Bulgarelli-Leva G. et al. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 1998; 282: 293-6.
  CrossrefPubMedGoogle Scholar
• 20 al-Aoukaty A, Rolstad B, Maghazachi AA. Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with G beta gamma after activation of NK cells with chemokines. J Immunol 1999; 162: 3249-55.
  PubMedGoogle Scholar
• 21 Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L. et al. Central role for G proteincoupled phosphoinositide 3-kinase gamma in inflammation. Science 2000; 287: 1049-53.
  CrossrefPubMedGoogle Scholar
• 22 Li Z, Jiang H, Xie W. et al. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 2000; 287: 1046-9.
  CrossrefPubMedGoogle Scholar
• 23 Sasaki T, Irie-Sasaki J, Jones RG. et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287: 1040-6.
  CrossrefPubMedGoogle Scholar
• 24 Condliffe AM, Davidson K, Anderson KE. et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005; 106: 1432-40.
  CrossrefPubMedGoogle Scholar
• 25 Wymann MP, Sozzani S, Altruda F. et al. Lipids on the move: phosphoinositide 3-kinases in leukocyte function. Immunol Today 2000; 21: 260-4.
  CrossrefPubMedGoogle Scholar
• 26 Okkenhaug K, Bilancio A, Farjot G. et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 2002; 297: 1031-4.
  PubMedGoogle Scholar
• 27 Thomas MJ, Smith A, Head DH. et al. Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. Eur J Immunol 2005; 35: 1283-91.
  CrossrefPubMedGoogle Scholar
• 28 Yum HK, Arcaroli J, Kupfner J. et al. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 2001; 167: 6601-8.
  CrossrefPubMedGoogle Scholar
• 29 Sadhu C, Dick K, Tino WT. et al. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 2003; 308: 764-9.
  CrossrefPubMedGoogle Scholar
• 30 Sadhu C, Masinovsky B, Dick K. et al. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 2003; 170: 2647-54.
  CrossrefPubMedGoogle Scholar
• 31 Puri KD, Doggett TA, Douangpanya J. et al. Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 2004; 103: 3448-56.
  CrossrefPubMedGoogle Scholar
• 32 Patrucco E, Notte A, Barberis L. et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 2004; 118: 375-87.
  CrossrefPubMedGoogle Scholar
• 33 Hannigan M, Zhan L, Li Z. et al. Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc Natl Acad Sci U S A 2002; 99: 3603-8.
  CrossrefPubMedGoogle Scholar
• 34 Rickert P, Weiner OD, Wang F. et al. Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol 2000; 10: 466-73.
  CrossrefPubMedGoogle Scholar
• 35 Del Prete A, Vermi W, Dander E. et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. Embo J 2004; 23: 3505-15.
  CrossrefPubMedGoogle Scholar
• 36 Ward SG. Do phosphoinositide 3-kinases direct lymphocyte navigation?. Trends Immunol 2004; 25: 67-74.
  CrossrefPubMedGoogle Scholar
• 37 Reif K, Okkenhaug K, Sasaki T. et al. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 2004; 173: 2236-40.
  CrossrefPubMedGoogle Scholar
• 38 Nombela-Arrieta C, Lacalle RA, Montoya MC. et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004; 21: 429-41.
  CrossrefPubMedGoogle Scholar
• 39 Rodriguez-Borlado L, Barber DF, Hernandez C. et al. Phosphatidylinositol 3-kinase regulates the CD4/CD8T cell differentiation ratio. J Immunol 2003; 170: 4475-82.
  CrossrefPubMedGoogle Scholar
• 40 Clayton E, Bardi G, Bell SE. et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 2002; 196: 753-63.
  CrossrefPubMedGoogle Scholar
• 41 Jou ST, Carpino N, Takahashi Y. et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 2002; 22: 8580-91.
  CrossrefPubMedGoogle Scholar
• 42 Webb LM, Vigorito E, Wymann MP. et al. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005; 175: 2783-7.
  CrossrefPubMedGoogle Scholar
• 43 Laffargue M, Calvez R, Finan P. et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 2002; 16: 441-51.
  CrossrefPubMedGoogle Scholar
• 44 Ali K, Bilancio A, Thomas M. et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004; 431: 1007-11.
  CrossrefPubMedGoogle Scholar
• 45 Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-79.
  CrossrefPubMedGoogle Scholar
• 46 Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999; 17: 931-72.
  CrossrefPubMedGoogle Scholar
• 47 Puri KD, Doggett TA, Huang CY. et al. The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood 2005; 106: 150-7.
  CrossrefPubMedGoogle Scholar
• 48 Vecchione C, Patrucco E, Marino G. et al. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. J Exp Med 2005; 201: 1217-28.
  CrossrefPubMedGoogle Scholar
• 49 Ishii S, Kuwaki T, Nagase T, Maki K. et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 1998; 187: 1779-88.
  CrossrefPubMedGoogle Scholar
• 50 Alloatti G, Levi R, Malan D. et al. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Cardiovasc Res 2003; 60: 242-9.
  CrossrefPubMedGoogle Scholar
• 51 Seki T, Yokoshiki H, Sunagawa M. et al. Angiotensin II stimulation of Ca2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002. Pflugers Arch 1999; 437: 317-23.
  CrossrefPubMedGoogle Scholar
• 52 Viard P, Exner T, Maier U. et al. Gbetagamma dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase. Faseb J 1999; 13: 685-94.
  CrossrefPubMedGoogle Scholar
• 53 Quignard JF, Mironneau J, Carricaburu V. et al. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J Biol Chem 2001; 276: 32545-51.
  CrossrefPubMedGoogle Scholar
• 54 Benham CD, Hess P, Tsien RW. Two types of calcium channels in single smooth muscle cells from rabbit ear artery studied with whole-cell and single-channel recordings. Circ Res 1987; 61: I10-6.
  PubMedGoogle Scholar
• 55 Steinberg SF. PI3King the L-type calcium channel activation mechanism. Circ Res 2001; 89: 641-4.
  PubMedGoogle Scholar
• 56 Le Blanc C, Mironneau C, Barbot C. et al. Regulation of vascular L-type Ca2+ channels by phosphatidylinositol 3,4,5-trisphosphate. Circ Res 2004; 95: 300-7.
  CrossrefPubMedGoogle Scholar
• 57 Viard P, Butcher AJ, Halet G. et al. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 2004; 07: 939-46.
  CrossrefPubMedGoogle Scholar
• 58 Go YM, Park H, Maland MC. et al. Phosphatidylinositol 3-kinase gamma mediates shear stress-dependent activation of JNK in endothelial cells. Am J Physiol 1998; 275: H1898-904.
  PubMedGoogle Scholar
• 59 Hirsch E, Bosco O, Tropel P. et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. Faseb J 2001; 15: 2019-21.
  CrossrefPubMedGoogle Scholar
• 60 Jackson SP, Schoenwaelder SM, Goncalves I. et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005; 11: 507-14.
  CrossrefPubMedGoogle Scholar
• 61 Lian L, Wang Y, Draznin J. et al. The relative role of PLCbeta and PI3Kgamma in platelet activation. Blood 2005; 106: 110-7.
  CrossrefPubMedGoogle Scholar
• 62 Bos JL, de Rooij J, Reedquist KA. Rap1 signalling: adhering to new models. Nat Rev Mol Cell Biol 2001; 02: 369-77.
  PubMedGoogle Scholar
• 63 Lova P, Paganini S, Sinigaglia F. et al. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 2002; 277: 12009-15.
  CrossrefPubMedGoogle Scholar
• 64 Woulfe D, Jiang H, Mortensen R. et al. Activation of Rap1B by G(i) family members in platelets. J Biol Chem 2002; 277: 23382-90.
  CrossrefPubMedGoogle Scholar
• 65 Lova P, Paganini S, Hirsch E, Barberis L, Wymann M, Sinigaglia F. et al. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem 2003; 278 (01) 131-8.
  CrossrefPubMedGoogle Scholar
• 66 Resendiz JC, Feng S, Ji G. et al. Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation. Mol Pharmacol 2003; 63: 639-45.
  CrossrefPubMedGoogle Scholar
• 67 Woulfe D, Jiang H, Morgans A. et al. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004; 113: 441-50.
  CrossrefPubMedGoogle Scholar
• 68 Chen J, De S, Damron DS. et al. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004; 104: 1703-10.
  CrossrefPubMedGoogle Scholar
• 69 Crackower MA, Oudit GY, Kozieradzki I. et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002; 110: 737-49.
  CrossrefPubMedGoogle Scholar
• 70 Camps M, Ruckle T, Ji H. et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11: 936-43.
  CrossrefPubMedGoogle Scholar
• 71 Schmidt EK, Fichelson S, Feller SM. PI3 kinase is important for Ras, MEK and Erk activation of Epostimulated human erythroid progenitors. BMC Biol 2004; 02: 7.
  CrossrefPubMedGoogle Scholar